← Open Payments lookup

EMMANUEL NWAPA: Open Payments

NPI 1922107788 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,619 in 82 payments from 16 companies in 2025. Trend: 2023 $651 · 2024 $919 · 2025 $1,619

Food & beverage: $1,619
CompanyPaymentsAmount
Alkermes, Inc.16$270
Otsuka America Pharmaceutical, Inc.11$233
Collegium Pharmaceutical, Inc.12$190
Neurocrine BioSciences, Inc.7$184
E.R. Squibb & Sons, L.L.C.9$149
ABBVIE INC.6$135
Janssen Pharmaceuticals, Inc3$94
Teva Pharmaceuticals USA, Inc.4$79
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$60
Almatica Pharma LLC2$51

Products named: ARISTADA, Jornay PM, REXULTI, INGREZZA, COBENFY, VRAYLAR, ABILIFY ASIMTUFII, INVEGA SUSTENNA.

Industry payments across NV — which companies pay providers there.